Greedy Insider · Filing
CTY · New 13D · ARCH Venture Fund XII, L.P. and affiliates
ARCH Venture Fund XII, L.P. and affiliates reported a 25.6% stake in City Therapeutics, Inc. (CTY) in a Schedule 13D filed on Oct 26, 2026, triggered by an event on Oct 19, 2026.
Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001193125-26-432028